Axelrod Felicia B, Gold-von Simson Gabrielle
Department of Pediatrics, New York University School of Medicine, New York, USA.
Orphanet J Rare Dis. 2007 Oct 3;2:39. doi: 10.1186/1750-1172-2-39.
The hereditary sensory and autonomic neuropathies (HSAN) encompass a number of inherited disorders that are associated with sensory dysfunction (depressed reflexes, altered pain and temperature perception) and varying degrees of autonomic dysfunction (gastroesophageal reflux, postural hypotention, excessive sweating). Subsequent to the numerical classification of four distinct forms of HSAN that was proposed by Dyck and Ohta, additional entities continue to be described, so that identification and classification are ongoing. As a group, the HSAN are rare diseases that affect both sexes. HSAN III is almost exclusive to individuals of Eastern European Jewish extraction, with incidence of 1 per 3600 live births. Several hundred cases with HSAN IV have been reported. The worldwide prevalence of HSAN type II is very low. This review focuses on the description of three of the disorders, HSAN II through IV, that are characterized by autosomal recessive inheritance and onset at birth. These three forms of HSAN have been the most intensively studied, especially familial dysautonomia (Riley-Day syndrome or HSAN III), which is often used as a prototype for comparison to the other HSAN. Each HSAN disorder is likely caused by different genetic errors that affect specific aspects of small fiber neurodevelopment, which result in variable phenotypic expression. As genetic tests are routinely used for diagnostic confirmation of HSAN III only, other means of differentiating between the disorders is necessary. Diagnosis is based on the clinical features, the degree of both sensory and autonomic dysfunction, and biochemical evaluations, with pathologic examinations serving to further confirm differences. Treatments for all these disorders are supportive.
遗传性感觉和自主神经病变(HSAN)包括一些遗传性疾病,这些疾病与感觉功能障碍(反射减退、疼痛和温度感知改变)以及不同程度的自主神经功能障碍(胃食管反流、体位性低血压、多汗)相关。在Dyck和Ohta提出的四种不同形式的HSAN数字分类之后,仍不断有其他类型被描述,因此识别和分类工作仍在进行。作为一个群体,HSAN是影响两性的罕见疾病。HSAN III几乎仅见于东欧犹太裔个体,活产发病率为1/3600。已报道了数百例HSAN IV病例。HSAN II型在全球的患病率非常低。本综述重点描述其中三种疾病,即HSAN II至IV型,其特征为常染色体隐性遗传且出生时起病。这三种形式的HSAN是研究最为深入的,尤其是家族性自主神经功能异常(莱利-戴综合征或HSAN III型),它常被用作与其他HSAN进行比较的原型。每种HSAN疾病可能由影响小纤维神经发育特定方面的不同基因错误引起,从而导致可变的表型表达。由于基因检测仅常规用于HSAN III型的诊断确认,因此需要其他方法来区分这些疾病。诊断基于临床特征、感觉和自主神经功能障碍的程度以及生化评估,病理检查用于进一步确认差异。所有这些疾病的治疗均为支持性治疗。